An exploration through uncharted territories
Picture a zebra fish brain.
This is just how little we know about the human brain today.
Shedding new light on the human brain is essential to create breakthrough neural therapies.
Shedding new light in decoding neural networks
-
Graphene unlocks the next generation of brain-computer interfaces (BCIs). It offers unprecedented selectivity and accuracy to effectively treat patients with neural conditions such as Parkinson’s disease, epilepsy, and speech impairment.
-
By decoding & modulating selectively & real time cortical and subcortical pathological biomarkers we have the potential to increase the precision, efficiency and efficacy of current standard of care
-
We design and develop with safety in mind. Our platform is compatible with robotics implantation and can be upgraded wirelessly to incorporate the latest innovations.
Sending a signal of hope
Solving the neural challenge doesn’t stop with the brain.
Our holistic approach goes beyond the brain to address the entire neural system, unlocking the full potential of our therapies to improve patients’ lives.
Together with Merck KGaA we are building INNERVIA Bioelectronics, a unique collaboration to create the next generation of highly selective bioelectronic therapies.
Scientific publications
-
Graphene in the Design and Engineering of Next-Generation Neural Interfaces
Advanced materials, 2017
Kostarelos et al. -
Full-bandwidth electrophysiology of seizures and epileptiform activity enabled by flexible graphene microtransistor depth neural probes
Nature nanotechnology, 2021
Garrido et al. -
High-resolution mapping of infraslow cortical brain activity enabled by graphene microtransistors
Nature materials, 2019
Masvidal et al.